90 related articles for article (PubMed ID: 30796053)
61. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
[TBL] [Abstract][Full Text] [Related]
62. Opposite angiogenic outcome of curcumin against ischemia and Lewis lung cancer models: in silico, in vitro and in vivo studies.
Fan S; Xu Y; Li X; Tie L; Pan Y; Li X
Biochim Biophys Acta; 2014 Sep; 1842(9):1742-54. PubMed ID: 24970744
[TBL] [Abstract][Full Text] [Related]
63. Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis.
Kim YJ; Bae J; Shin TH; Kang SH; Jeong M; Han Y; Park JH; Kim SK; Kim YS
J Control Release; 2015 Oct; 216():56-68. PubMed ID: 26260451
[TBL] [Abstract][Full Text] [Related]
64. Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model.
Matsumoto K; Obara N; Ema M; Horie M; Naka A; Takahashi S; Imagawa S
Cancer Sci; 2009 Sep; 100(9):1639-47. PubMed ID: 19575748
[TBL] [Abstract][Full Text] [Related]
65. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
66. Location, location, location: macrophage positioning within tumors determines pro- or antitumor activity.
Rivera LB; Bergers G
Cancer Cell; 2013 Dec; 24(6):687-9. PubMed ID: 24332035
[TBL] [Abstract][Full Text] [Related]
67. Chromogranin A in cardiovascular endocrinology.
Goetze JP; Hilsted LM; Rehfeld JF
Acta Physiol (Oxf); 2021 Apr; 231(4):e13615. PubMed ID: 33460488
[No Abstract] [Full Text] [Related]
68. The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide.
Robles JP; Zamora M; Siqueiros-Marquez L; Adan-Castro E; Ramirez-Hernandez G; Nuñez FF; Lopez-Casillas F; Millar RP; Bertsch T; Martínez de la Escalera G; Triebel J; Clapp C
Angiogenesis; 2022 Feb; 25(1):57-70. PubMed ID: 34097181
[TBL] [Abstract][Full Text] [Related]
69. Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma.
Reni M; Andreasi V; Gasparri AM; Dugnani E; Colombo B; Macchini M; Bianco M; Dallatomasina A; Citro A; Assi E; Protti MP; Esposito A; Falconi M; Curnis F; Piemonti L; Corti A
Front Oncol; 2020; 10():613582. PubMed ID: 33425767
[TBL] [Abstract][Full Text] [Related]
70. Relationship between neuropilin-1 expression and prognosis, according to gastric cancer histology.
Seo HS; Hyeon J; Song IH; Lee HH
J Mol Histol; 2020 Apr; 51(2):199-208. PubMed ID: 32242307
[TBL] [Abstract][Full Text] [Related]
71. Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation.
Mahata SK; Corti A
Ann N Y Acad Sci; 2019 Nov; 1455(1):34-58. PubMed ID: 31588572
[TBL] [Abstract][Full Text] [Related]
72. The chromogranin A
Rocca C; Grande F; Granieri MC; Colombo B; De Bartolo A; Giordano F; Rago V; Amodio N; Tota B; Cerra MC; Rizzuti B; Corti A; Angelone T; Pasqua T
Acta Physiol (Oxf); 2021 Apr; 231(4):e13570. PubMed ID: 33073482
[TBL] [Abstract][Full Text] [Related]
73. Regulation of tumor growth by circulating full-length chromogranin A.
Curnis F; Dallatomasina A; Bianco M; Gasparri A; Sacchi A; Colombo B; Fiocchi M; Perani L; Venturini M; Tacchetti C; Sen S; Borges R; Dondossola E; Esposito A; Mahata SK; Corti A
Oncotarget; 2016 Nov; 7(45):72716-72732. PubMed ID: 27683038
[TBL] [Abstract][Full Text] [Related]
74. Quantification of Chromogranin A and Its Fragments in Biological Fluids.
Curnis F; Colombo B; Corti A
Methods Mol Biol; 2023; 2565():343-359. PubMed ID: 36205905
[TBL] [Abstract][Full Text] [Related]
75. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
76. Neuropilin-1 and Integrins as Receptors for Chromogranin A-Derived Peptides.
Corti A; Anderluzzi G; Curnis F
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559048
[TBL] [Abstract][Full Text] [Related]
77. Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement.
Dallatomasina A; Gasparri AM; Colombo B; Sacchi A; Bianco M; Daniele T; Esposito A; Pastorino F; Ponzoni M; Marcucci F; Curnis F; Corti A
Cancer Res; 2019 Apr; 79(8):1925-1937. PubMed ID: 30796053
[TBL] [Abstract][Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]